Experts: Dr Dawn Chaplin & Ms Geraldine Burge

Experts: Prof Mike Morgan & Ms Jane Scullion

Experts: Dr Brendan Cooper & Mrs Angela Evans

Expert: Professor Peter Calverley

TIM GRIFFITHS MEMORIAL LECTURE - Cross cultural links with other diseases - Prof Mike Morgan - Activity Monitoring - what is new, what is old, is it needed - Dr Richard Zuwallack - How to maintain activity levels in everyday life? - Prof Sally Singh - Mediating or moderating activity levels in COPD: anxiety and depression - Prof Paula Meed

- Immunosubversion & Immunorestitution - Dr Martin Stampfli - Autoimmunity - Prof Alvar Agusti - Problems and benefits of Proteomics - Prof Philip Johnson

- Introduction to current issues and achieving a holistic approach - Dr Noel O'Kelly - Palliative Care and Dyspnea Management in End Stage COPD - Dr Richard Mularski - Controversies in oxygen therapy - Christine Mikelsons - Management of COPD cachexia - Prof Rich Casaburi

- Interventional bronchoscopy (stenting) - Dr Frank Sciurba - Systemic versus local therapy - Prof Rob Stockley - Bio behavioural issues - Dr Jan Vercoulen - Can genetic testing predict COPD? - Prof Ian Hall

- Lung maturation - Prof David Warburton - Stem cells and regenerative medicine - Prof Stephen Rennard - Animal models what is the bottom line - Prof Andrew Churg

- Developing patient reported quality measures - Prof Paul Jones - Metrics and Indicators - can we achieve them - Prof Mike Pearson - what can be done in primary care - Dr Kevin Grifydd-Jones - What do patients really want (professional patients) - John Walsh & Dame Helena Shovelton, Round table discussion

- National COPD strategy - an English approach - Professor Sue Hill - Delivering high quality care for patients - Dr Robert Winter - A solution across the primary secondary care divide (IMPRESS) - tbc - Developing the workforce - tbc

Admissions avoidance - Dr Lisa Davies Ventilatory support - Prof Mark Elliott Prophylactic therapy - Prof Wisia Wedzicha Structured admission - Dr Roger Goldstein

- COPD and lung cancer at the molecular level - Prof Avi Spira - Lung and bone; what's beneath the COPD - Osteoporosis link - Dr Charlotte Bolton - Myoremediation - Dr David Glass - Atherosclerosis - Emphysema of the blood vessels - Dr Magnus Back

- Assessment & management of acute exacerbations - Dr John Hurst - Does early pulmonary rehabilitation work? - Prof Thierry Troosters - Exacerbation follow-up - Prof Wisia Wedzicha - How can we effectively prevent hospital admission in COPD - Dr Marc Miravitlles

- Lung function decline - Prof James Crapo - Phenotypes - Prof David Lomas - Exacerbations: COPD susceptibility, emphysema and airway disease - Prof Edwin Silverman

What is the data telling us? - Dr Don Sin Why does it matter? - Dr Maarten van den Berge What should we do? - Prof Sonia Buist

Experts: Paula Meek & Sue Lareau

Experts: Dr Dr Bilton

Expert: Professor Bart Celli

Experts: Prof Christine Jenkins & Ms Sam Prigmore

Experts: Dr Brendan Cooper & Prof Mike Pearson